Home> Products> Inhibitors> (±)-Bisoprolol hemifumarate-CAS 104344-23-2
price inquiry for CAS:104344-23-2, Product:(±)-Bisoprolol hemifumarate

(±)-Bisoprolol hemifumarate CAS: 104344-23-2

Category: Inhibitors
Product Name: (±)-Bisoprolol hemifumarate
Cat No: I000247
CAS No: 104344-23-2
Synonyms: (E)-but-2-enedioic acid;1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
Molecular Formula: C22H35NO8
Molecular Weight: 441.52
SMILES: CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O
InChI: None
InChIKey: None
Solubility: DMSO 88 mg/mL Water 88 mg/mL Ethanol 88 mg/mL
Target: Adrenergic Receptor
Storage: powder
CAS 104344-23-2,(±)-Bisoprolol hemifumarate
  • Description

Bisoprolol is a selective type β1 adrenergic receptor blocker.
Target: Adrenergic Receptor
Approved: July 31, 1992
Bisoprolol, on beta 1-adrenoceptor peptide induced autoimmune myocardial damage. In the animal model of autoimmune cardiomyopathy induced by active immunization of rabbits with beta 1-adrenoceptor peptide, bisoprolol was given at a dose of 3 mg/day throughout the study period. Our results showed high titer of anti-beta 1-adrenoceptor antibody in the immunized group throughout the study but not in the group receiving only bisoprolol [1]. Bisoprolol administration resulted in a significant reduction in HR reaching 60.3 +/- 1.4 bpm at VT of 500 mL (compared to 70.5 +/- 1.8 bpm with placebo, P < 0.001). Changes in HP were also significant with an increase in HP reaching 1004.5 +/- 22.2 msec at this controlled VT (compared to 860.3 +/- 21.5 msec with placebo, P < 0.001) [2].
Toxicity: Oral, mouse: LD50 = 100 mg/kg; Skin, rabbit: LD50 = 200 mg/kg; Skin, rat: LD50 = 500 mg/kg. Symptoms of overdose include congestive heart failure (marked by sudden weight gain, swelling of the legs, feet, and ankles, fatigue, and shortness of breath), difficult or labored breathing, low blood pressure, low blood sugar, and slow heartbeat.

  • Spec

Appearance:Solid powder
Purity: > 98%

  • References


[1]. Matsui, S., et al., Protective effect of bisoprolol on beta-1 adrenoceptor peptide-induced autoimmune myocardial damage in rabbits. Herz, 2000. 25(3): p. 267-70.
[2]. Wargon, M., et al., Acute effects of bisoprolol on respiratory sinus arrhythmia. Fundam Clin Pharmacol, 1998. 12(4): p. 451-6.


price inquiry for CAS:104344-23-2, Product:(±)-Bisoprolol hemifumarate